Key facts
- This page summarizes Brian Linscott's Form 4 filing for HARTE HANKS INC (HHS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 May 2023, 12:33.
Brian Linscott - 26 May 2023 Form 4 Insider Report for HARTE HANKS INC (HHS)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- HHS
- Reported as of
- 26 May 2023
- Net transaction value
- -$9,406
- SEC form
- 4
- Accepted by SEC
- 26 May 2023, 12:33:01 UTC
- Prior SEC filing
- 24 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Laurilee Kearnes, Attorney-in-Fact for Brian Linscott
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brian Linscott filed Form 4 for HARTE HANKS INC (HHS) on 26 May 2023.
Change
- Previous filing in this sequence was filed on 24 May 2023.
- Current net transaction value: -$9,406.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HHS
transaction
Common Stock
Tax liability
- Transaction value
- $9,406
- Shares
- -1,633
- Change %
- -0.49%
- Price
- $5.76
- Shares after
- 328,985
- Date
- 26 May 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares withheld to offset the reporting person's tax obligations upon vesting of the Restricted Stock Units.